14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
HAO vs DOO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Haoxi Health Technology Limited Class A (HAO) is the stronger overall head-to-head candidate over DOO (DOO) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). HAO carries a Unified Composite Score of 45.2/100 (HOLD) at $2.00 (N/M Forward P/E, -14.9% operating margin), whereas DOO carries 45.3/100 (HOLD) at $63.52 (N/M Forward P/E, N/A operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HAO vs DOO. Trailing 12-month operating profitability (HAO -14.9% vs DOO N/A) and valuation multiples (HAO N/M vs DOO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ HAO vs DOO Key Questions & Quantitative Answers
As of Nov 16, 2026, Haoxi Health Technology Limited Class A (HAO) is the stronger overall head-to-head candidate over DOO (DOO) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). HAO carries a Unified Composite Score of 45.2/100 (HOLD) at $2.00 (N/M Forward P/E, -14.9% operating margin), whereas DOO carries 45.3/100 (HOLD) at $63.52 (N/M Forward P/E, N/A operating margin). Technically, HAO sits in a Neutral phase (RSI 47.2, UNCLASSIFIED options structure) and DOO sits in a Neutral phase (RSI 56.1, UNCLASSIFIED options structure).
HAO leads the Growth & Scale pillar: HAO posts +137.3% YoY revenue growth and +172.7% YoY earnings growth on $55M TTM revenue (1.1% gross margin, -14.9% operating margin), compared with DOO at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, HAO generates $55M in USD-normalized revenue versus N/A for DOO. In operating R&D and SG&A reinvestment, HAO deploys 16.0% of Rev ($8.8M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for DOO.
HAO and DOO trade at balanced relative valuation multiples. HAO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-14.3% EBITDA margin), whereas DOO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HAO (-54.1% ROE) versus DOO (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, HAO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (7.50β · 151% Vol realized risk). By comparison, DOO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.86β · 42% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.